Department of Clinical Neurosciences, UCL Institute of Neurology, Royal Free Campus, Rowland Hill Street, London NW3 2PF, United Kingdom.
Curr Neuropharmacol. 2013 Jan;11(1):30-40. doi: 10.2174/157015913804999432.
The majority of studies investigating the molecular pathogenesis and cell biology underlying dystonia have been performed in individuals with primary dystonia. This includes monogenic forms such as DYT1and DYT6 dystonia, and primary focal dystonia which is likely to be multifactorial in origin. In recent years there has been renewed interest in non-primary forms of dystonia including the dystonia-plus syndromes and heredodegenerative disorders. These are caused by a variety of genetic mutations and their study has contributed to our understanding of the neuronal dysfunction that leads to dystonia These findings have reinforced themes identified from study of primary dystonia including abnormal dopaminergic signalling, cellular trafficking and mitochondrial function. In this review we highlight recent advances in the understanding of the dystonia-plus syndromes and heredodegenerative dystonias.
大多数研究探索了原发性肌张力障碍患者的肌张力障碍的分子发病机制和细胞生物学。这包括 DYT1 和 DYT6 肌张力障碍等单基因形式,以及可能源于多种因素的原发性局灶性肌张力障碍。近年来,人们对非原发性肌张力障碍形式(包括肌张力障碍伴发综合征和遗传性进行性疾病)重新产生了兴趣。这些疾病是由各种基因突变引起的,它们的研究有助于我们了解导致肌张力障碍的神经元功能障碍。这些发现强化了从原发性肌张力障碍研究中确定的主题,包括异常的多巴胺能信号、细胞运输和线粒体功能。在这篇综述中,我们强调了对肌张力障碍伴发综合征和遗传性进行性肌张力障碍的理解的最新进展。